Democrats will fight tooth and nail to save Obamacare, but given the flaws in the plan, they are not likely to succeed. Obamacare in its current form is the walking dead.

Trump has said that he will replace Obamacare with something better. In his speeches, Trump outlined certain key points of his plan that investors can use to look ahead to search for opportunities.

A big change in health care is coming. The key for investors to profit handsomely with low risk is to identify opportunities in stage one of the five stages of change.

Please click here to see five stages of a trade based on change.

Before I describe specific opportunities from TrumpCare, it is important for investors to gain some perspective by looking at the long-term chart.

Chart

The chart is a monthly inter-market analysis chart going back to the current bull market.

Please click here for inter-market chart comparing various health care sectors.

The chart compares S&P 500 ETF SPY, -2.08% and big general health care ETF, the Health Care Select Sector SPDR ETF XLV, -0.86% to the SPDR S&P Health Care Services ETF XHS, -2.17% , the PowerShares Exchange-Traded Fund Trust Dynamic Pharmaceuticals Portfolio PJP, -1.32% , the SPDR S&P Biotech ETF XBI, -2.71% and iShares U.S. Medical Devices ETF IHI, -1.21% .

For those who are not used to inter-market analysis charts, they at first seem daunting. Take a few minutes to look at the chart and get a good idea of where everything stands.

Import drugs

Trump has talked about importing drugs to reduce prices. The same drugs cost a lot less abroad than they do in the United States. In the short term, the nonsensical hysteria to buy pharmaceutical stocks may continue because Clinton did not get elected. However, over the long term, big pharma stocks such as Pfizer PFE, -0.54% , Bristol-Myers BMY, +0.11% , Johnson & Johnson JNJ, +0.46% , Merck MRK, -0.15% , Abbot ABT, -2.10% , AbbVie ABBV, -1.18% , and Lilly LLY, -0.42% are likely to come under pressure. In other words very, very short-term traders can take advantage by buying these stocks, but long-term investors may consider selling into the strength.

If current buying gets overdone, it might be an attractive opportunity for aggressive investors to scale in shorts in these stocks.

Insurance across state lines

Trump is a big proponent of selling insurance across state lines. This may increase competition for Humana HUM, -0.22% , United Health Care UNH, -0.46% , Aetna US:AET, Anthem ANTM, -0.02% , and Cigna CI, -0.18% . These stocks are likely to come under pressure if Trump implements his plan. Very short-term traders can take advantage of this by buying these stocks to take advantage of the current rally, but long-term investors may consider selling into the strength.

Ironically, such a move by Trump may provide advantage for large national chain hospitals such as HCA Holdings HCA, -3.36% , Community Health Systems CYH, -5.08% and Tenet Healthcare THC, -7.40% . These stocks are being mercilessly beaten on since the Trump victory. When they become cheap enough, it will be an opportunity for the long-term investors to buy them.

Block grants

Trump has talked about replacing parts of Medicaid with block grants to states. By necessity, states will turn to Medicaid insurance companies such as Centene Corp CNC, +1.38% , Molina Healthcare MOH, -2.61% , and WellCare Health WCG, +1.35% . These stocks are also being mercilessly beaten on Trump victory. When they become cheap enough, it will be an opportunity for the long-term investors to buy them.

Cash repatriation

Trump is committed to passing legislation that will allow big pharma to repatriate billions of dollars of cash trapped overseas to the United States at attractive tax rates. Big pharma flush with cash is likely to go shopping. Some of the buyout candidates include: BioMarin BMRN, -0.93% , Vanda VNDA, +2.71% , Alexion ALXN, -1.76% , Puma PBYI, -4.07% , Jazz JAZZ, -1.07% , Aria US:ARIA , and Kite US:KITE. At The Arora Report, to date 115 of our portfolio companies have been bought out generating handsome profits.

More Trump stocks

Stocks in infrastructure, coal, steel and precious metal sectors are moving on Trump victory. Please click here to read our take on these 32 stocks and ETFs.

What to do now

Keep a close eye on the companies and ETFs mentioned above and buy or sell them as recommended above based on technicals assuming no new fundamental changes and Trump follows through with the basic elements of his plan. Of course, at The Arora Report we will closely follow these opportunities with actionable signals.

Disclosure: Subscribers toThe Arora Reportmay have positions in the securities mentioned in this article and/or may take positions in securities described in this article any time. All recommended positions are reviewed daily at The Arora Report.